Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by sponsor or company

Search by sponsors

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “Roche”

A Study of Atezolizumab in Participants With Programmed Death - Ligand 1 (PD-L1) Positive Locally Advanced or Metastatic Non-Small Cell Lung CancerCompleted
NCT02031458Phase 2Updated Jan 6, 2020
Sponsor: Hoffmann-La Roche
Non-Small Cell Lung Cancer
United States, Australia, Belgium, Bosnia and Herzegovina, Bulgaria +14 more
Rituximab and Involved Field Radiotherapy in Early Stage Follicular LymphomaCompleted
NCT00509184Phase 2Updated Jan 6, 2020
Sponsor: Klaus Herfarth, MD
Lymphoma, Malignant
Germany
A Long Term Extension of Study NC19453 Evaluating Safety and Efficacy of RO4607381Completed
NCT00400439Phase 2Updated Jan 3, 2020
Sponsor: Hoffmann-La Roche
Coronary Heart Disease
United States
A Study of the Effect of RO4607381 on Atherosclerotic Plaque in Patients With Coronary Heart DiseaseCompleted
NCT00655473Phase 2Updated Jan 3, 2020
Sponsor: Hoffmann-La Roche
Coronary Heart Disease
United States, Canada
A Study of RO4607381 in Stable Coronary Heart Disease Patients With Recent Acute Coronary SyndromeCompleted
NCT00658515Phase 3Updated Jan 3, 2020
Sponsor: Hoffmann-La Roche
Coronary Heart Disease
United States, Argentina, Australia, Austria, Belgium +24 more
A Study Assessing the Effect of RO4607381 on Vascular Function in Patients With Coronary Heart Disease (CHD) or CHD-Risk Equivalent PatientsCompleted
NCT00655538Phase 2Updated Jan 2, 2020
Sponsor: Hoffmann-La Roche
Coronary Heart Disease
Austria, France, Germany, Italy, Netherlands +2 more
A Study to Assess the Effect of RO4607381 in Patients With Relatively Low Levels of High Density Lipoprotein-Cholesterol (HDL-C)Completed
NCT00697203Phase 2Updated Jan 2, 2020
Sponsor: Hoffmann-La Roche
Dyslipidemia
United States
An Observational Study to Register the Incidence of Breast Cancer and Current Clinical Care Patterns in KenyaCompleted
NCT01484483N/AUpdated Dec 23, 2019
Sponsor: Hoffmann-La Roche
Breast Cancer
Kenya
A Study of Atezolizumab (an Engineered Anti-Programmed Death-Ligand 1 [PD-L1] Antibody) as Monotherapy or in Combination With Bevacizumab (Avastin®) Compared to Sunitinib (Sutent®) in Participants With Untreated Advanced Renal Cell CarcinomaCompleted
NCT01984242Phase 2Updated Dec 23, 2019
Sponsor: Hoffmann-La Roche
Renal Cell Carcinoma
United States, Czechia, France, Germany, Italy +4 more
A Study of Erlotinib in Participants With Locally Advanced or Metastatic Non-Small Cell Lung CancerCompleted
NCT01667562Phase 3Updated Dec 20, 2019
Sponsor: Hoffmann-La Roche
Non-Small Cell Lung Cancer
Serbia
A Study of Atezolizumab Compared With Docetaxel in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Failed Platinum-Containing TherapyCompleted
NCT02008227Phase 3Updated Dec 20, 2019
Sponsor: Hoffmann-La Roche
Non-Squamous Non-Small Cell Lung Cancer
United States, Argentina, Austria, Brazil, Canada +26 more
A Formulation Screening Study of Dalcetrapib and Atorvastatin in Healthy VolunteersCompleted
NCT01363999Phase 1Updated Dec 17, 2019
Sponsor: Hoffmann-La Roche
Healthy Volunteer
New Zealand
Study of Atezolizumab in Combination With Cobimetinib in Participants With Locally Advanced or Metastatic Solid TumorsCompleted
NCT01988896Phase 1Updated Dec 17, 2019
Sponsor: Hoffmann-La Roche
Solid Tumors
United States, Australia, Canada, Germany, Singapore +1 more
A Study of the Metabolic Profile of Dalcetrapib in Healthy VolunteersCompleted
NCT01476267Phase 1Updated Dec 17, 2019
Sponsor: Hoffmann-La Roche
Healthy Volunteer
Netherlands
A Study to Evaluate Pertuzumab + Trastuzumab + Docetaxel vs. Placebo + Trastuzumab + Docetaxel in Previously Untreated HER2-Positive Metastatic Breast CancerCompleted
NCT00567190Phase 3Updated Dec 13, 2019
Sponsor: Genentech, Inc.
Metastatic Breast Cancer
United States, Argentina, Brazil, Canada, China +21 more
A Study of Selicrelumab (RO7009789) in Combination With Atezolizumab in Participants With Locally Advanced and/or Metastatic Solid TumorsCompleted
NCT02304393Phase 1Updated Dec 13, 2019
Sponsor: Hoffmann-La Roche
Solid Tumors
United States, Canada, Denmark, France, Netherlands +1 more
A Safety Study of Balsamic Bactrim in Pediatric Participants With Acute BronchitisCompleted
NCT02879981N/AUpdated Dec 13, 2019
Sponsor: Hoffmann-La Roche
Bronchitis
Peru
A Study to Investigate Efficacy and Safety of Cobimetinib Plus Atezolizumab and Atezolizumab Monotherapy Versus Regorafenib in Participants With Metastatic Colorectal Adenocarcinoma (COTEZO IMblaze370)Completed
NCT02788279Phase 3Updated Dec 11, 2019
Sponsor: Hoffmann-La Roche
Colorectal Cancer
United States, Australia, Belgium, Canada, Hong Kong +6 more
A Non-Interventional Study in Patients With Moderate to Severe Rheumatoid Arthritis Treated With RoActemra/Actemra (Tocilizumab)Completed
NCT01663506N/AUpdated Dec 10, 2019
Sponsor: Hoffmann-La Roche
Rheumatoid Arthritis
Estonia
Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) in Unresectable or Metastatic Gastric and Gastroesophageal Junction AdenocarcinomaCompleted
NCT00515411Phase 2Updated Dec 10, 2019
Sponsor: Memorial Sloan Kettering Cancer Center
Gastroesophageal Junction Adenocarcinoma · Gastric Cancer
United States
Non-Interventional Study of Tocilizumab Subcutaneous (SC) Monotherapy in Participants With Rheumatoid Arthritis (RA)Completed
NCT02402686N/AUpdated Dec 6, 2019
Sponsor: Hoffmann-La Roche
Rheumatoid Arthritis
Hungary
Evaluation of Hypertension as a Predictor of Efficacy Bevacizumab in Metastatic Breast Cancer and Colorectal CancerCompleted
NCT01733628N/AUpdated Dec 4, 2019
Sponsor: Spanish Breast Cancer Research Group
Metastatic Colorectal Cancer · Metastatic Breast Cancer
Spain
The Importance of Muscle Function in Patients With Disseminated Bladder CancerUnknown
NCT04144270N/AUpdated Nov 20, 2019
Sponsor: Rigshospitalet, Denmark
Urinary Bladder Neoplasm
Denmark
Bevacizumab and Trabectedin +/- Carboplatin in Advanced Ovarian CancerCompleted
NCT01735071Phase 2Updated Nov 19, 2019
Sponsor: Mario Negri Institute for Pharmacological Research
Ovarian Epithelial Cancer Recurrent
Italy
Blood Sample Monitoring of Patients With EGFR Mutated Lung CancerUnknown
NCT02284633N/AUpdated Nov 12, 2019
Sponsor: Aarhus University Hospital
Lung Neoplasms
Denmark

Previous page Next page